Stock screenerAll disclosures →
EDGAR →
HYPR
Conviction 18HealthcareScan · Mon, Aug 10, 2026HYPR$0.9561+0.12%
ResistanceSupportVol 14Insider sell2
Vol MA14 585.19K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.9561
Change+0.12%
Gap+2.59%
Rel volume1.17×
Avg volume720.46K
Avg $ vol695.81K
SMA 200.9667
SMA 501.22
SMA 2001.20
Price vs 50-21.53%
Price vs 200-20.28%
MA stackmixed
50/200 cross—
Supertrenddown · 1.14
RSI (14)39
MACD hist0.02
MACD crossbull · 7d
Stoch %K / %D45 / 50
ADX (14)20
+DI / −DI15 / 19
RSI divergenceBullish
MACD divergenceBullish
ATR %+8.39%
ADR %7.12%
52w high2.20
52w low0.8910
From 52w high-56.54%
Above 52w low+7.31%
New 52w highNo
SqueezeOn · 2d
Bollinger width14.77%
%B0.43
Donchian pos38.05%
Donchian high1.08
Donchian low0.8800
AVWAP (52w high)1.28
vs AVWAP high-25.05%
AVWAP (52w low)1.28
vs AVWAP low-25.34%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d1.17×
Avg vol (14d)585.19K
Avg vol (20d)720.46K
Avg $ vol (20d)695.81K
Market cap78.2M
RS 3m (vs SPY)-48.85%
RS 6m (vs SPY)-22.29%
RS line new highNo
Trend template1/8
Technical rank13.6
1 week-2.56%
1 month-12.28%
3 months-43.43%
6 months-13.08%
1 year-16.86%
YTD-1.32%
P/E-2.20
P/B2.13
P/S5.77
P/FCF-2.68
EPS-0.4300
Div yield—
ROE-96.78%
ROA-56.47%
Debt/Eq0.36
Current6.15
EV/EBITDA-1.33
Gross margin49.79%
Net margin-262.29%
Rev growth5.22%
EPS growth12.64%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value47.98M
Revenue3.9M
Net income-9.3M
Gross profit1.98M
Free cash flow-29.13M
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
ExchangeNasdaq
Shares out84.22M
Employees102
ListedThu, Dec 23, 2021
Free float69.41M
Float %83.2%
Short interest2.57M
Days to cover2.6d
Short volume62.1%
Squeeze score38 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank13.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.69
Support0.8950
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HYPR
No recent disclosed trades by Congress in HYPR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in HYPR · 5 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Wolterman Dan Director · Stock Options (right to buy) · 2026-06-03 | Grant | 52.6K | $0 | 2026-06-03 | 2026-06-04 |
HALE BRETT CFO and CAO · Class A Common Stock · 2026-05-26 | Sell | 6.05K | $10K | 2026-05-26 | 2026-05-27 |
TEISSEYRE THOMAS Chief Operating Officer · Class A Common Stock · 2026-05-26 | Sell | 6.05K | $10K | 2026-05-26 | 2026-05-27 |
Wolterman Dan Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
ROTHBERG JONATHAN M Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
Dahldorf John T Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
Fattori Ruth A Director · Stock Options (right to buy) · 2026-05-22 | Grant | 157.7K | $0 | 2026-05-22 | 2026-05-22 |
SEC filings
EDGAR filings in HYPR · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.